Assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia with biochemical markers N-terminal pro brain natriuretic peptide (NT-proBNP), cardiac troponin T (cTnT) and creatine kinase MB (CK-MB mass). NT-proBNP seems to be a promising marker for assessment of cardiotoxicity in the peritransplant period.
Negative cTnT and CK-MB mass concentrations show no detectable damage of cardiomyocyte structure.